by Jordana Choucair | Mar 4, 2022 | D.C. News
The Senate narrowly passed a resolution to terminate the national emergency declaration for the COVID-19 pandemic. The resolution passed 48 to 47 on a party-line vote, underscoring political pressure the Biden administration could face to unwind pandemic-related...
by Jordana Choucair | Mar 4, 2022 | Health IT
Surgeon General Dr. Vivek Murthy has asked technology companies, health care providers, and community organizations for information about COVID-19 misinformation. It is the Biden administration’s first attempt to get tech firms to share such data publicly....
by Jordana Choucair | Mar 4, 2022 | Life Sciences
Civica Rx, the nonprofit generic drug company created by a consortium of hospitals, announced that it plans to lower the cost of insulin by making it on its own. Civica plans to manufacture and distribute three different kinds of insulin at a cost of no more than $30...
by Jordana Choucair | Mar 4, 2022 | Opioid/Substance Use Disorders
OxyContin maker Purdue Pharma and the Sackler family have struck an agreement to pay up to $6 billion to settle lawsuits over the company’s role in fueling the opioid crisis. The new settlement is up from the $4.55 deal reached last year and is contingent upon...
by Jordana Choucair | Mar 3, 2022 | Mental Health
The Biden administration released a 96-page plan for the next phase of the COVID-19 pandemic. The National COVID-19 Preparedness Plan outlines a roadmap for averting economic and educational shutdowns in the event of future case surges and calls for additional...
Recent Comments